NASDAQ: TWST
Twist Bioscience Corporation
Healthcare · Medical - Diagnostics & Research
Market Cap
$5.45B
52w High
$88.46
52w Low
$23.30
P/E
-66.47
Volume
3.93M
Outstanding Shares
62.27M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 143.97% over the last year. Revenue grew 17.77% over the trailing twelve months. Operating margin moved from -57.86% to -33.9%. Free cash flow declined 45.27% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 57th percentile of their historical P/S range.
What would invalidate this read
Operating margin is at -33.9%. Revenue grew 17.77% — this thesis depends on that trajectory holding. Despite the price move, free cash flow fell 45.27%, which is worth watching as a leading indicator of future pressure. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
11
Buy
1
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 3, 2026
Q3 FY26 · EPS est -$0.50 · Revenue est $114.54M
View